Page last updated: 2024-08-25

5-hydroxymethylcytosine and Atherosclerosis

5-hydroxymethylcytosine has been researched along with Atherosclerosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, G; Gao, L; Hu, C; Jiang, D; Lu, K; Sun, M; Tao, H; Wu, S; You, L; Zhang, D1
Jiang, ZS; Li, AF; Li, GH; Li, RQ; Liu, LS; Peng, J; Ren, Z; Tang, XQ; Tang, ZH; Wang, Z; Wei, DH; Yang, Q; Zheng, XL1
Li, H; Luan, P; Peng, W; Wang, K; Xu, Y; Zhang, P; Zhuang, J1

Other Studies

3 other study(ies) available for 5-hydroxymethylcytosine and Atherosclerosis

ArticleYear
DNA methylation and hydroxymethylation are associated with the degree of coronary atherosclerosis in elderly patients with coronary heart disease.
    Life sciences, 2019, May-01, Volume: 224

    Topics: 5-Methylcytosine; Aged; Atherosclerosis; Case-Control Studies; Coronary Disease; Dioxygenases; DNA Methylation; DNA-Binding Proteins; Epigenesis, Genetic; Female; Gene Expression Regulation; Humans; Leukocytes, Mononuclear; Male; Proto-Oncogene Proteins; Up-Regulation

2019
Tet methylcytosine dioxygenase 2 inhibits atherosclerosis via upregulation of autophagy in ApoE-/- mice.
    Oncotarget, 2016, 11-22, Volume: 7, Issue:47

    Topics: 5-Methylcytosine; Animals; Apolipoproteins E; Atherosclerosis; Autophagy; Cytokines; Dioxygenases; Disease Models, Animal; DNA Methylation; DNA-Binding Proteins; Gene Expression; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Immunohistochemistry; Inflammation Mediators; Lipoproteins, LDL; Male; Mice; Mice, Knockout; Plaque, Atherosclerotic; Proto-Oncogene Proteins

2016
The Yin-Yang Dynamics of DNA Methylation Is the Key Regulator for Smooth Muscle Cell Phenotype Switch and Vascular Remodeling.
    Arteriosclerosis, thrombosis, and vascular biology, 2017, Volume: 37, Issue:1

    Topics: 5-Methylcytosine; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Azacitidine; Cell Dedifferentiation; Cell Movement; Cell Proliferation; Cells, Cultured; Decitabine; Diet, High-Fat; Dioxygenases; Disease Models, Animal; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA-Binding Proteins; Enzyme Inhibitors; Epigenesis, Genetic; Genetic Predisposition to Disease; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nuclear Proteins; Phenotype; Promoter Regions, Genetic; Proto-Oncogene Proteins; Rats; Signal Transduction; Time Factors; Trans-Activators; Vascular Remodeling

2017